Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Department of Internal Medicine I, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.
Nutrients. 2021 Jun 8;13(6):1977. doi: 10.3390/nu13061977.
Current treatment recommendations for non-alcoholic fatty liver disease (NAFLD) rely heavily on lifestyle interventions. The Mediterranean diet and physical activity, aiming at weight loss, have shown good results in achieving an improvement of this liver disease. However, concerns related to compliance and food accessibility limit the feasibility of this approach, and data on the long-term effects on liver-related outcomes are lacking. Insulin resistance is a central aspect in the pathophysiology of NAFLD; therefore, interventions aiming at the improvement of insulin sensitivity may be preferable. In this literature review, we provide a comprehensive summary of the available evidence on nutritional approaches in the management of NAFLD, involving low-calorie diets, isocaloric diets, and the novel schemes of intermittent fasting. In addition, we explore the harmful role of single nutrients on liver-specific key metabolic pathways, the role of gene susceptibility and microbiota, and behavioral aspects that may impact liver disease and are often underreported in clinical setting. At present, the high variability in terms of study populations and liver-specific outcomes within nutritional studies limits the generalizability of the results and highlights the urgent need of a tailored and standardized approach, as seen in regulatory trials in Non-Alcoholic Steatohepatitis (NASH).
目前,非酒精性脂肪性肝病(NAFLD)的治疗建议主要依赖于生活方式干预。地中海饮食和体力活动旨在减轻体重,已显示出在改善这种肝病方面的良好效果。然而,与依从性和食物可及性相关的问题限制了这种方法的可行性,并且缺乏关于长期肝脏相关结局影响的数据。胰岛素抵抗是 NAFLD 病理生理学的核心方面;因此,旨在改善胰岛素敏感性的干预措施可能更为可取。在这篇文献综述中,我们全面总结了关于管理 NAFLD 的营养方法的现有证据,包括低热量饮食、等热量饮食和间歇性禁食的新方案。此外,我们探讨了单一营养素对肝脏特定关键代谢途径的有害作用、基因易感性和微生物群的作用,以及可能影响肝脏疾病且在临床环境中经常未被充分报道的行为方面。目前,营养研究中研究人群和肝脏特异性结局的高度变异性限制了结果的普遍性,并突出了迫切需要一种量身定制和标准化的方法,就像在非酒精性脂肪性肝炎(NASH)的监管试验中看到的那样。